Wordt geladen...
Sotatercept in patients with osteolytic lesions of multiple myeloma
This phase IIa study evaluated the safety and tolerability of sotatercept, and its effects on bone metabolism and haematopoiesis in newly diagnosed and relapsed multiple myeloma (MM) patients. Patients were randomized (4:1) to receive four 28-d cycles of sotatercept (0·1, 0·3, or 0·5 mg/kg) or place...
Bewaard in:
| Gepubliceerd in: | Br J Haematol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Ltd
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4312883/ https://ncbi.nlm.nih.gov/pubmed/24650009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12835 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|